Status
Conditions
Treatments
About
This study is the multi-center, open and cross-sectional study of RA remission in Asia Pacific region. The objectives is to explore remission rate of RA patients in different countries in the Asian-Pacific area using different criteria of remission (DAS28, CDAI, SDAI, ACR/EULA remission criteria, RAPID3 and Clin28) and investigate the associated factors of remission in RA patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1,500 participants in 1 patient group
Loading...
Central trial contact
Ru Li, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal